The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006

British Journal of Sports Medicine

Volumn 42, Issue 9, 2008, Pages 725-730

  Tscholl, P ^a   Junge, A ^a   Dvorak, J ^a  

^a SCHULTHESS CLINIC   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIOXIDANT; ANTITUSSIVE AGENT; BENZOIC ACID DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE; CARNITINE; CORTICOSTEROID; CREATINE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; HERBACEOUS AGENT; KETOPROFEN; LOCAL ANESTHETIC AGENT; MINERAL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROTON PUMP INHIBITOR; PSYCHOTROPIC AGENT; TRACE ELEMENT; UBIDECARENONE; UNINDEXED DRUG; VITAMIN;

ARTICLE; ATHLETE; DIET SUPPLEMENTATION; DRUG USE; FOOTBALL; HUMAN; MACRONUTRIENT; MEDICAL DOCUMENTATION; OINTMENT; PHYSICIAN; PRESCRIPTION; PROSPECTIVE STUDY;

ADRENAL CORTEX HORMONES; ADULT; ANALGESICS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIETARY SUPPLEMENTS; DOPING IN SPORTS; DRUG UTILIZATION; HUMANS; MALE; MICRONUTRIENTS; MUSCLE RELAXANTS, CENTRAL; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RESPIRATORY SYSTEM AGENTS; SOCCER;

EID: 52249121948     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2007.045187     Document Type: Article

References (31)

1. Dvorak J, Graf-Baumann T, D'Hooghe M, et al. FIFA's approach to doping in football. Br J Sports Med 2006;40(Suppl I):i3-12.
2. Saugy M, Robinson N, Saudan C, et al. Human growth hormone doping in sport. Br J Sports Med 2006; 40(Suppl l):i35-9.
3. Robinson N, Giraud S, Saudan C, et al. Erythropoietin and blood doping. Br J Sports Med 2006;40(Suppl l):i30-4.
4. Anderson SD, Sue-Chu M, Perry CP, et al. Bronchial challenges in athletes applying to inhale a β2-agonist at the 2004 Summer Olympics. J Allergy Clin Immunol 2006;117:767-73.
5. Houglum JE. Pharmacological Considerations in the Treatment of Injured Athletes with Nonsteroidal Anti-Inflammatory Drugs. J Athl Train 1998;33:259-63.
6. Paoloni JA, Orchard JW. The use of therapeutic medications for soft-tissue injuries in sports medicine. MJA 2005;183:384-8.
7. Baker J, Cotter JD, Gerrard DF, et al. Effects of indomethacin and celecoxib on renal function in athletes. Med Sci Sports Exerc 2005;37:712-7.
8. Dvorak J, Feddermann N, Grimm K. Glucocorticosteroids in football: use and misuse. Br J Sports Med 2006;40(Suppl l):i48-54.
9. Huang SH, Johnson K, Pipe AL. The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic Games. Clin J Sport Med 2006;16:27-33.
10. Corrigan B, Kazlauskas R. Medication Use in Athletes Selected for Doping Control at the Sydney Olympics (2000). Clin J Sport Med 2003;13:33-40.
11. Alaranta A, Alaranta H, Holmila J, et al. Self-reported attitudes of elite athletes towards doping: differences between type of sport. Int J Sports Med 2005;27:842-6.
12. Waddington I, Malcolm D, Roderick M, et al. Drug use in English professional football. Br J Sports Med 2005;39(4):e18.
13. Taioli E. Use of permitted drugs in Italian professional soccer players. Br J Sports Med 2007;41:439-41.
14. Schwenk TL, Costley CD, When Food becomes a Drug: Nonanabolic Nutritional Supplement Use in Athletes. Am J Ortho Soc Sports Med 2002;30:907-16.
15. FIFA, Regulations - Doping Control. Available at http://de.fifa.com/mm/document/afdeveloping/medical/6.17. %20fifa%20doping%20control%20regulations_1533.pdf.
16. http://www.cks.library.nhs.uk/nsaids/view_whole_guidance. Nonsteroidal antiinflammatory drugs (NSAIDs). NHS Guidelines 2007 (accessed 9 January 2008).
17. Martin B. Körperliche Aktivität in der Schweizer Bevölkerung: Niveau und Zusammenhänge mit der Gesundheit. Schweiz Z Sportmed Sporttraumatol 2000;48:87-8.
18. Alampi G. Arzneimittelgebrauch im Breitensport. Basel, 1999.
19. Drawer S, Fuller CW. Propensity for osteoarthritis and lower limb joint pain in retired professional soccer players. Br J Sports Med 2001;35:402-8.
20. Berntzen G, Roarsen O, Stenersen SA, et al. [Injuries and drug use among soccer players], Tidsskr Nor Laegeforen 1996;116:1996-9.
21. Mottram DR Drugs in Sport Taylor & Francis Ltd, 2005.
22. Kennedy MC, Kennedy JR. Ethics of prescribing drugs to enhance sporting performance. Med J Aust 1999;171:204-5.
23. Alaranta A, Alaranta H, Heliövaara M, et al. Ample use of physician-prescribed medications in Finnish elite athletes. Int J Sports Med 2006;27:919-25.
24. Orchard JW. Benefits and risks of using local anaesthetic for pain relief to allow early return to play in professional football. Br J Sports Med 2002;36:209-13.
25. Maroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol 2006;65:326-31.
26. Dieppe PA, Ebrahim S, Martin RM, et al. Lessons from the withdrawal of rofecoxib. BMJ 2004;329:867-8.
27. Virchenko O, Skoglund B, Aspenberg P. Parecoxib impairs early tendon repair but improves later remodeling. Am J Sports Med 2004;32:1743-7.
28. Warden SJ, Avin KG, Beck EM, et al. Low-intensity pulsed ultrasound accelerates and a nonsteroidal anti-inflammatory drug delays knee ligament healing. Am J Sports Med 2006;34:1094-102.
29. Porucznik CA, Reeser JC, Willick S, et al. Use of pain medication among collegiate club volleyball players. Med Sci Sports Exerc 2007;39(5 Suppl):S394.
30. Burke L, Deakin V. Clinical Sports Nutrition. Sydney: McGraw-Hill Australia, 2006.
31. Geyer H, Parr MK, Mareck U, et al. Analysis of non-hormonal nutritional supplements for anabolic androgenic steroids - results of the international IOC study. Int J Sports Med 2004;25:124-9.